These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 19284568)

  • 21. Anti-Cancer Potential of
    An EJ; Kim Y; Lee SH; Ko HM; Chung WS; Jang HJ
    Molecules; 2020 May; 25(10):. PubMed ID: 32422890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells.
    Fan Y; Zhang YL; Wu Y; Zhang W; Wang YH; Cheng ZM; Li H
    World J Gastroenterol; 2008 Jan; 14(3):428-34. PubMed ID: 18200666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
    J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
    Hawthorne VS; Huang WC; Neal CL; Tseng LM; Hung MC; Yu D
    Mol Cancer Res; 2009 Apr; 7(4):592-600. PubMed ID: 19372587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
    Wang X; Goldstein D; Crowe PJ; Yang JL
    Anticancer Res; 2014 Nov; 34(11):6537-45. PubMed ID: 25368256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.
    Sen B; Peng S; Woods DM; Wistuba I; Bell D; El-Naggar AK; Lai SY; Johnson FM
    Clin Cancer Res; 2012 Jan; 18(1):127-39. PubMed ID: 22090359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro.
    Huang C; Cao J; Huang KJ; Zhang F; Jiang T; Zhu L; Qiu ZJ
    Cancer Sci; 2006 Dec; 97(12):1417-23. PubMed ID: 17054436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
    Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
    PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells.
    Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH
    Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma.
    Kesanakurti D; Chetty C; Dinh DH; Gujrati M; Rao JS
    Oncogene; 2013 Jan; 32(3):327-40. PubMed ID: 22349830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous silencing of β-catenin and signal transducer and activator of transcription 3 synergistically induces apoptosis and inhibits cell proliferation in HepG2 liver cancer cells.
    Wang XH; Liu MN; Huang P; Xu J; Liu AY; Chen J; Lv CQ; Xu RL
    Mol Med Rep; 2015 Aug; 12(2):2263-8. PubMed ID: 25845340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockage of STAT3 Signaling Pathway by Morusin Induces Apoptosis and Inhibits Invasion in Human Pancreatic Tumor Cells.
    Kim C; Kim JH; Oh EY; Nam D; Lee SG; Lee J; Kim SH; Shim BS; Ahn KS
    Pancreas; 2016 Mar; 45(3):409-19. PubMed ID: 26646273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines.
    Glienke W; Hausmann E; Bergmann L
    Tumour Biol; 2011 Jun; 32(3):493-500. PubMed ID: 21174186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Apoptosis resistance induced by leptin and its mechanism in breast cancer cells].
    Zhao TS; Jiang HP; Wang XC; Ren H; Hao JH
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):651-4. PubMed ID: 20021858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
    Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M; Li C; Lin J; Javle M
    Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.